Vault-13

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · CIK 1892134 · 13F filing filed 2023-02-07

SEC-registered investment adviser since 2021 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Palo Alto, CA (main office)United States United Statesabout 44
San Diego, CAUnited States United States3

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.6bn reported value +23.8% vs Q3 2022
44positions
66.4%in top 10
7 new 9 added 5 reduced 6 sold out vs Q3 2022

Holdings, Q4 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 HILLEVAX INC COM COM 9,758,359 $163.3m10.15% 10.15% UnchangedShares held: Q3 2022 9.8m, Q4 2022 9.8m
2 IMAGO BIOSCIENCES INC COM COM 3,987,207 $143.3m8.91% 8.91% AddedShares held: Q3 2022 3.0m, Q4 2022 4.0m +1.0m +1,015,933 34.2%
3 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,684,232 $128.5m7.99% 7.99% UnchangedShares held: Q3 2022 8.7m, Q4 2022 8.7m
4 CHINOOK THERAPEUTICS INC COM ADRO ADRO 4,345,559 $113.9m7.08% 7.08% AddedShares held: Q3 2022 4.3m, Q4 2022 4.3m +80.0k +80,000 1.9%
5 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 9,341,551 $101.8m6.33% 6.33% NewShares held: Q3 2022 0, Q4 2022 9.3m
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,708,838 $94.4m5.87% 5.87% AddedShares held: Q3 2022 3.4m, Q4 2022 3.7m +296.0k +296,000 8.7%
7 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 8,407,152 $94.3m5.86% 5.86% UnchangedShares held: Q3 2022 8.4m, Q4 2022 8.4m
8 KRYSTAL BIOTECH INC COM KRYS KRYS 999,737 $79.2m4.92% 4.92% ReducedShares held: Q3 2022 1.0m, Q4 2022 999.7k -18.7k -18,651 -1.8%
9 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,860,107 $75.3m4.68% 4.68% AddedShares held: Q3 2022 3.8m, Q4 2022 3.9m +32.3k +32,326 0.8%
10 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 2,815,720 $73.6m4.57% 4.57% AddedShares held: Q3 2022 2.1m, Q4 2022 2.8m +716.2k +716,179 34.1%
11 VAXCYTE INC COM PCVX PCVX 1,397,405 $67.0m4.17% 4.17% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.4m -150.0k -150,000 -9.7%
12 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 1,894,000 $55.2m3.43% 3.43% UnchangedShares held: Q3 2022 1.9m, Q4 2022 1.9m
13 ALLAKOS INC COM ALLKG ALLKG 4,792,000 $40.3m2.51% 2.51% UnchangedShares held: Q3 2022 4.8m, Q4 2022 4.8m
14 ANAPTYSBIO INC COM ANAB ANAB 899,700 $27.9m1.73% 1.73% UnchangedShares held: Q3 2022 899.7k, Q4 2022 899.7k
15 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,787,527 $26.2m1.63% 1.63% UnchangedShares held: Q3 2022 1.8m, Q4 2022 1.8m
16 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,414,823 $25.9m1.61% 1.61% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m
17 REPLIMUNE GROUP INC COM REPL REPL 931,560 $25.3m1.58% 1.58% AddedShares held: Q3 2022 806.3k, Q4 2022 931.6k +125.3k +125,293 15.5%
18 COGENT BIOSCIENCES INC COM COGT COGT 2,109,154 $24.4m1.52% 1.52% AddedShares held: Q3 2022 2.1m, Q4 2022 2.1m +35.0k +35,000 1.7%
19 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,985,757 $21.9m1.36% 1.36% UnchangedShares held: Q3 2022 3.0m, Q4 2022 3.0m
20 KALVISTA PHARMACEUTICALS INC COM KALV KALV 3,238,859 $21.9m1.36% 1.36% AddedShares held: Q3 2022 1.6m, Q4 2022 3.2m +1.7m +1,666,667 106.0%
21 GRITSTONE BIO INC COM GRTS GRTS 5,162,348 $17.8m1.11% 1.11% ReducedShares held: Q3 2022 5.2m, Q4 2022 5.2m -75.0k -75,000 -1.4%
22 SUTRO BIOPHARMA INC COM COM 1,776,479 $14.4m0.89% 0.89% UnchangedShares held: Q3 2022 1.8m, Q4 2022 1.8m
23 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 857,338 $13.6m0.85% 0.85% UnchangedShares held: Q3 2022 857.3k, Q4 2022 857.3k
24 SILENCE THERAPEUTICS PLC ADS SLN SLN 881,173 $13.4m0.84% 0.84% UnchangedShares held: Q3 2022 881.2k, Q4 2022 881.2k
25 TREVI THERAPEUTICS INC COM TRVI TRVI 6,663,590 $12.9m0.80% 0.80% AddedShares held: Q3 2022 5.4m, Q4 2022 6.7m +1.3m +1,260,000 23.3%
26 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 393,000 $12.4m0.77% 0.77% UnchangedShares held: Q3 2022 393.0k, Q4 2022 393.0k
27 MERUS N V COM MRUS MRUS 746,479 $11.5m0.72% 0.72% UnchangedShares held: Q3 2022 746.5k, Q4 2022 746.5k
28 VECTIVBIO HLDG AG ORD SHS ORD SHS 1,333,400 $11.5m0.71% 0.71% NewShares held: Q3 2022 0, Q4 2022 1.3m
29 AVIDITY BIOSCIENCES INC COM RNA RNA 500,000 $11.1m0.69% 0.69% NewShares held: Q3 2022 0, Q4 2022 500.0k
30 IMMUNOVANT INC COM IMVT IMVT 585,759 $10.4m0.65% 0.65% UnchangedShares held: Q3 2022 585.8k, Q4 2022 585.8k
31 TYRA BIOSCIENCES INC COM TYRA TYRA 1,327,665 $10.1m0.63% 0.63% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.3m
32 BLUEBIRD BIO INC COM COM 1,440,757 $10.0m0.62% 0.62% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m
33 ARVINAS INC COM ARVN ARVN 285,331 $9.8m0.61% 0.61% UnchangedShares held: Q3 2022 285.3k, Q4 2022 285.3k
34 PROTHENA CORP PLC SHS PRTA PRTA 127,900 $7.7m0.48% 0.48% NewShares held: Q3 2022 0, Q4 2022 127.9k
35 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,746,857 $7.1m0.44% 0.44% UnchangedShares held: Q3 2022 3.7m, Q4 2022 3.7m
36 INTELLIA THERAPEUTICS INC COM NTLA NTLA 203,684 $7.1m0.44% 0.44% UnchangedShares held: Q3 2022 203.7k, Q4 2022 203.7k
37 THESEUS PHARMACEUTICALS INC COM COM 1,398,194 $7.0m0.43% 0.43% NewShares held: Q3 2022 0, Q4 2022 1.4m
38 PASSAGE BIO INC COM COM 3,756,915 $5.2m0.32% 0.32% UnchangedShares held: Q3 2022 3.8m, Q4 2022 3.8m
39 ZYMEWORKS INC COM ZYME ZYME 610,000 $4.8m0.30% 0.30% NewShares held: Q3 2022 0, Q4 2022 610.0k
40 ACLARIS THERAPEUTICS INC COM ACRS ACRS 290,189 $4.6m0.28% 0.28% ReducedShares held: Q3 2022 408.3k, Q4 2022 290.2k -118.1k -118,140 -28.9%
41 ESSA PHARMA INC COM NEW EPI EPI 605,141 $1.5m0.09% 0.09% ReducedShares held: Q3 2022 692.9k, Q4 2022 605.1k -87.8k -87,769 -12.7%
42 APTINYX INC COM COM 1,883,244 $537.3k0.03% 0.03% UnchangedShares held: Q3 2022 1.9m, Q4 2022 1.9m
43 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 500,333 $434.3k0.03% 0.03% NewShares held: Q3 2022 0, Q4 2022 500.3k
44 NABRIVA THERAPEUTICS PLC SHS NEW 2022 NBRVF NBRVF 17,025 $32.2k0.00% 0.00% UnchangedShares held: Q3 2022 17.0k, Q4 2022 17.0k

Sold out since Q3 2022

SecurityTickerShares held beforeValue then
TRICIDA INC TCDA TCDA 2,549,671 $26.7m2.5m shares
FRAZIER LIFESCIENCES ACQU CO 1,501,000 $15.2m1.5m shares
GRACELL BIOTECHNOLOGIES INC 2,890,102 $9.3m2.9m shares
MACROGENICS INC MGNX MGNX 701,631 $2.4m701.6k shares
PARDES BIOSCIENCES INC 845,636 $1.6m845.6k shares
MOLECULAR TEMPLATES INC 1,374,047 $1.0m1.4m shares